The annual meeting of the European Society of Medical Oncology (ESMO) kicks off in Paris on 9 September.and early indications are the event could be full of pra 29 August 2022
Shares in liver and cardio-metabolic specialist 89bio were up 5% ahead of the opening bell on Friday, following positive Phase II results from the ENTRIGUE stud 26 August 2022
The anti-amyloid beta (Aβ) protofibril antibody lecanemab is not just a potentially crucial medicine for Alzheimer’s patients and for drug companies Eisai, Biog 5 August 2022
One year on from the historic approval of the first new Alzheimer’s med in decades, the world’s largest event focused on the disease is set to take place in San 22 July 2022
A proposed biosimilar to Soliris (eculizumab) has shown clinical equivalence in efficacy and safety in people with paroxysmal nocturnal hemoglobinuria (PNH). 12 July 2022
Stockholm-based biotech Swedish Orphan Biovitrum and French drugmaker Sanofi have presented positive results from the XTEND-1 Phase III study evaluating the saf 11 July 2022
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.